| [1] | STRATTON IM, ADLER AI, NEIL HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35): Prospective observational study[J]. BMJ, 2000, 321(7258): 405. doi: 10.1136/bmj.321.7258.405 |
| [2] | 中华医学会内分泌学分会. 糖尿病患者血糖波动管理专家共识[J]. 药品评价, 2017, 14(17): 5. |
| [3] | LU J, MA X, ZHOU J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care, 2018, 41(11): 2370. doi: 10.2337/dc18-1131 |
| [4] | BECK RW, BERGENSTAL RM, RIDDLESWORTH TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials[J]. Diabetes Care, 2019, 42(3): 400. doi: 10.2337/dc18-1444 |
| [5] | 王平, 单忠艳, 姜雅秋. 波动性高血糖与糖尿病慢性并发症相关性研究进展[J]. 中国实用内科杂志, 2016, 36(11): 1003. |
| [6] | 段建芳, 金凤钟, 王晓明, 等. 血糖波动与老年人糖尿病血管并发症的研究进展[J]. 中华老年多器官疾病杂志, 2016, 15(10): 788. |
| [7] | LU J, MA X, ZHANG L, et al. Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: a preliminary study[J]. Diabetes Res Clin Pract, 2020, 161: 108032. doi: 10.1016/j.diabres.2020.108032 |
| [8] | The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy[J]. Ann Intern Med, 1995, 122(8): 561. doi: 10.7326/0003-4819-122-8-199504150-00001 |
| [9] | CHEHREGOSHA H, KHAMSEH ME, MALEK M, et al. A view beyond HbA1c: role of continuous glucose monitoring[J]. Diabetes Ther, 2019, 10(3): 853. doi: 10.1007/s13300-019-0619-1 |
| [10] | 包玉倩. 糖化血红蛋白: 优势犹在, 无可替代[J]. 中华糖尿病杂志, 2020, 12(1): 17. |